|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2011-3-3
|
|
pubmed:abstractText |
HIV-1 V3 quasispecies was analyzed by ultra-deep pyrosequencing, in early HIV-infected patients, to assess possible correlations between quasispecies diversity, frequency of variants predicted to use CXCR4 and need for early antiretroviral treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1473-5571
|
|
pubmed:author |
pubmed-author:AbbateIsabellaI,
pubmed-author:BartoliniBarbaraB,
pubmed-author:BrusellesAlessandroA,
pubmed-author:CapobianchiMaria RMR,
pubmed-author:CorpolongoAngelaA,
pubmed-author:D'OffiziGianpieroG,
pubmed-author:DesideriAlessandroA,
pubmed-author:GiombiniEmanuelaE,
pubmed-author:IppolitoGiuseppeG,
pubmed-author:NarcisoPasqualeP,
pubmed-author:RozeraGabriellaG,
pubmed-author:VlassiChrysoulaC
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
13
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
611-7
|
|
pubmed:meshHeading |
pubmed-meshheading:21160417-Adult,
pubmed-meshheading:21160417-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:21160417-Female,
pubmed-meshheading:21160417-Genetic Variation,
pubmed-meshheading:21160417-HIV Infections,
pubmed-meshheading:21160417-HIV Seropositivity,
pubmed-meshheading:21160417-HIV-1,
pubmed-meshheading:21160417-Humans,
pubmed-meshheading:21160417-Male,
pubmed-meshheading:21160417-Middle Aged,
pubmed-meshheading:21160417-Proviruses,
pubmed-meshheading:21160417-RNA, Viral,
pubmed-meshheading:21160417-Receptors, CXCR4,
pubmed-meshheading:21160417-Retrospective Studies,
pubmed-meshheading:21160417-Sequence Analysis, DNA,
pubmed-meshheading:21160417-Young Adult
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Detection of quasispecies variants predicted to use CXCR4 by ultra-deep pyrosequencing during early HIV infection.
|
|
pubmed:affiliation |
Laboratory of Virology, Clinical Department, National Institute of Infectious Diseases INMI, Lazzaro Spallanzani, Italy. isabella.abbate@inmi.it
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
